Clear cell sarcoma of the kidney (CCSK) is a rare tumor of childhood. The National Wilms Tumor Study Group (NWTSG) identifies it as one of the most common unfavorable histology tumors. Approximately 20 new cases of CCSK are diagnosed each year in the United States.
Epidemiology Disease Associations Pathogenesis Laboratory/Radiologic/
Other Diagnostic Testing
Gross Appearance and Clinical Variants Histopathological Features and Variants Special Stains/
Differential Diagnosis Prognosis Treatment Commonly Used Terms Internet Links
EPIDEMIOLOGY CHARACTERIZATION SYNONYMS CCSK
PATHOGENESIS CHARACTERIZATION p53
Infrequent p53 Gene Mutations and Lack of p53 Protein Expression in Clear Cell Sarcoma of the Kidney: Immunohistochemical Study and Mutation Analysis of p53 in Renal Tumors of Unfavorable Prognosis.
Hsueh C, Wang H, Gonzalez-Crussi F, Lin JN, Hung IJ, Yang CP, Jiang TH.
Department of Pathology (CH), Department of Surgery (JNL) and Department of Pediatrics (IJH, CPY, THJ), Chang Gung Children's Hospital, Tao Yuan, Taiwan, R.O.C.
Mod Pathol 2002 Jun;15(6):606-10 Abstract quote
A high prevalence of p53 gene mutation and protein expression has been found in the anaplastic variant of Wilms' tumor (WT), known to be associated with poor outcome. However, there are very few studies of p53 alterations in the other two rare and highly malignant renal tumors in childhood, in other words, clear cell sarcoma of the kidney (CCSK) and malignant rhabdoid tumor of the kidney (MRTK). Overexpression of p53 protein has been detected in eight CCSKs in one study, and in two in another, yet no molecular correlation with p53 gene mutations has been carried out.
Our study is the first molecular analysis concerning p53 in CCSK. We investigated eight cases of CCSK and one case of MRTK for p53 protein expression by immunohistochemical staining. All were analyzed for p53 mutations in the region of exons 4 to 8 by polymerase chain reaction-single-strand conformational polymorphism (PCR-SSCP) method and DNA sequencing analysis. By histological study, no CCSK showed anaplastic features. None expressed p53 protein, but two harbored p53 mutations. One was in exon 5, with a base pair insertion between codons 162 to 163 causing frameshift alteration in amino acid. Another was a silent CTC-->CTT transversion in codon 289 of exon 8. The case of MRTK did not show any alterations of p53 protein or gene.
Our result indicates that p53 alterations are infrequent in CCSK and do not seem to be primary genetic events in the pathogenesis of CCSK.
HISTOLOGICAL TYPES CHARACTERIZATION General
Am J Surg Pathol 2000;24:4
91% of the tumors had the classic pattern as either a predominant or a secondary morphology, a majority also demonstrated one or more variant patterns
These patterns usually blended smoothly with the classic pattern or another variant pattern
1. Myxoid pattern (50%)
2. Sclerosing pattern (35%)
3. Cellular pattern (26%)
4. Epithelioid pattern (trabecular or acinar type) (13%)
5. Palisading (verocay-body) pattern (11%)
6. Spindle cell pattern (7%)
7. Storiform pattern (4%)
8. Anaplastic pattern (2.6%)
Clear Cell Sarcoma of the Kidney A Review of 351 Cases From the National Wilms Tumor Study Group Pathology Center
Pedram Argani, M.D.; Elizabeth J. Perlman, M.D.; Norman E. Breslow, Ph.D.; Nancy G. Browning, M.S.; Daniel M. Green, M.D.; Giulio J. D'Angio, M.D.; J. Bruce Beckwith, M.D.
From the Department of Pathology, The Johns Hopkins Hospital, Baltimore, Maryland (P.A., E.J.P.); the Department of Biostatistics, University of Washington, Seattle, Washington (N.E.B.); the Department of Pathology and Human Anatomy, Loma Linda University, Loma Linda, California (N.G.B., J.B.B.); the Department of Pediatrics, Roswell Park Cancer Institute, Buffalo, New York (D.M.G.); and the Department of Radiation Oncology, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, U.S.A. (G.J.D.).
Am J Surg Pathol 2000;24:4 Abstract quote
We reviewed 351 cases of clear cell sarcoma of the kidney (CCSK), including 182 cases entered on National Wilms Tumor Study Group (NWTSG) trials 1–4 for which clinical follow-up information was available.
Tumors were restaged using NWTS 5 criteria. Mean age at diagnosis in the NWTS group was 36 months with a range of 2 months to 14 years. The male to female ratio was 2:1. Typical gross features included large size (mean diameter 11.3 cm), a mucoid texture, foci of necrosis, and prominent cyst formation.
Nine major histologic patterns were identified (classic, myxoid, sclerosing, cellular, epithelioid, palisading, spindle, storiform, and anaplastic); virtually all tumors contained multiple patterns that blended with one another.
Immunohistochemical stains were performed on 45 cases; only vimentin was consistently immunoreactive. Consistently negative results with other antibodies helped exclude other tumors in the differential diagnosis; all CCSKs were cytokeratin-negative, including epithelioid tumors that mimicked Wilms tumor, and MIC2-negative, including cellular tumors that mimicked primitive neuroectodermal tumor. The p53 gene product was rarely overexpressed in non-anaplastic CCSKs, but strikingly overexpressed in two of three anaplastic CCSKs. Overall survival was 69%.
Multivariate analysis revealed four independent prognostic factors for survival: treatment with doxorubicin, stage, age at diagnosis, and tumor necrosis. Of note, stage 1 patients had a remarkable 98% survival rate. No other histologic or clinical variable independently correlated with survival.
VARIANTS Clear cell sarcoma of the kidney: report of a case with mandibular metastasis simulating a benign myxomatous tumor Oral Surg Oral Med Oral Pathol 1988;65:567–74. Anaplastic subset
Am J Surg Pathol 2000;24:4
Defined by nuclear hyperchromasia, nuclear gigantism, and atypical mitoses
Anaplasia appears to arise de novo
Dramatic p53 overexpression in the anaplastic foci of two tumors in which the non-anaplastic regions did not overexpress p53
CHARACTERIZATION Special stains Immunoperoxidase
Negative for most other markers
DIFFERENTIAL DIAGNOSIS KEY DIFFERENTIATING FEATURES ANAPLASTIC SARCOMA OF THE KIDNEY
- Anaplastic Sarcoma of the Kidney: A Clinicopathologic Study of 20 Cases of a New Entity With Polyphenotypic Features.
*Department of Histopathology, School of Medicine, Cardiff University, Cardiff †Department of Pediatric Pathology, Royal Manchester Childrenʼs Hospital, Manchester, UK ‡Department of Pathology, Childrenʼs Memorial Hospital, Chicago, IL §Childhood Cancer Research Unit, Karolinska Institute, Astrid Lindgrenʼs Childrenʼs Hospital, Stockholm, Sweden ∥Pathology and Human Anatomy, Loma Linda University School of Medicine, Loma Linda, CA.
- Am J Surg Pathol. 2007 Oct;31(10):1459-1468. Abstract quote
We report 20 cases of a distinct, previously unrecognized renal neoplasm, anaplastic sarcoma of the kidney with polyphenotypic features. The tumors were identified by rereviewing tumors with unusual anaplastic features from the National Wilms Tumor Study Pathology Center, the International Society of Pediatric Oncology and the United Kingdom Children's Cancer Study Group trials.
Patients ranged in age from 10 months to 41 years (median age 5 y, mean age 12 y) and females predominated (1.5:1). Twelve tumors presented in the right kidney, and 5 in the left (laterality was unknown in 3 cases). The most common presentation was a renal mass. Grossly, most tumors were large, measured 4 to 21 cm (mean 12.7 cm) and weighed 115 to 1820 g (mean 835 g). Seven out of 12 tumors suitable for assessment had a distinct cystic component. The tumors involved the pelvi-calyceal system in 5 of the cases.
Histologically, all tumors showed a spindle cell component which contained either multiple foci or diffuse, widespread anaplastic changes with bizarre pleomorphic cells and very atypical mitotic figures. Chondroid differentiation was seen in 16 cases, usually in the form of islands of hyaline cartilage (13 cases) or chondroid matrix (3 cases). The nodules of cartilage showed both benign and malignant features, often within the same tumor. In 2 cases small foci of osteoid were found whereas osteoclastlike giant cells were seen in 4 cases. Only 3 of the tumors exhibited a primitive blastemalike area. No neoplastic epithelial structures were identified. No nephrogenic rests were found. Limited immunohistochemical studies showed vimentin positivity in 5/5 cases, desmin was positive in 4/6 cases, MYF4 showed focal weak nuclear positivity in 1/4 cases, but MyoD1 was negative in all cases (0/5). PGP9.5 was focally, strongly positive in 4/5 cases and p53 was strongly positive in 3/6 cases. Cytokeratin, using the antibody CAM5.2, was uniformly negative within the tumor cells. Finally, CD56 was focally positive in 1/6 tumors, whereas all other markers were negative including NB84a (4/4), CD34 (5/6), CD99 (5/5), and WT1 (6/6 cases).
In 4 tumors reverse transcriptase-polymerase chain reaction was performed to detect the SYT-SSX fusion transcript produced by the t(x;18), and the ETV6-NTRK3 fusion transcript using RNA extracted from archived paraffin blocks-results were negative in all 4 specimens. Tumor stage was known in 15 patients including 7 stage I, 4 stage II, 3 stage III, and 1 stage IV tumors. They were usually diagnosed as anaplastic Wilms tumors and treated accordingly.
Of the 13 patients with a minimum of 2 years follow-up, 4 patients developed distant metastases and 1 had local recurrence including 1 patient with stage IV, 2 with stage III, and 2 with stage I at presentation. Three of them died and 2 were lost to follow-up. One patient with stage I tumor developed widespread metastases and died. Another stage I patient developed local recurrence after 3 months of diagnosis, but was lost to follow-up. Five stage I patients were alive and free of tumor at last follow-up. The most common sites of metastases were lung (3 cases), and liver and bones (2 cases each).
These tumors showed pathologic features similar to the pleuropulmonary blastoma of childhood and undifferentiated (embryonal) sarcoma of the liver. In the differential diagnosis, anaplastic Wilms tumor, primary renal synovial sarcoma, malignant mesenchymoma, ectomesenchymoma, and mesenchymal chondrosarcomas have been considered but none of these tumors shared the same features as the 20 cases described here which represent a distinct clinicopathologic entity with morphologic features of a polyphenotypic anaplastic sarcoma of the kidney. Further molecular studies are needed to better understand its nature and more accurate classification.
Blastemal Wilms tumor and PNET
More aggressively invasive than CCSK, entrapping whole islands of native renal parenchyma as opposed to the single tubules entrapped by CCSK
Coarser chromatin than CCSK
Consistent MIC2 negativity in CCSK
Distinction of epithelioid CCSK patterns, particularly acinar types, from the true tubular differentiation of a Wilms tumor
No CCSK expressed cytokeratin regardless of how epithelioid the appearance
Plump cell variant of cellular congenital mesoblastic nephroma, metanephric stromal tumor
Predominantly spindled CCSKs can be difficult to distinguish
Characteristic fine chromatin of CCSK
All CCSKs in our study stained negatively for desmin and S100 protein, A significant percentage of congenital mesoblastic nephromas stain with desmin
Metanephric Stromal Tumor Report of 31 Cases of a Distinctive Pediatric Renal Neoplasm
Pedram Argani, M.D.; J. Bruce Beckwith, M.D.
From the Department of Pathology, The Johns Hopkins Hospital, Baltimore, Maryland, U.S.A. (P.A.); the Department of Pathology, Loma Linda University School of Medicine, Loma Linda, California, U.S.A. (J.B.B.); and the National Wilms Tumor Study Group Pathology Center.
Am J Surg Pathol 2000;24:917-926 Abstract quote
We report 31 cases of a novel pediatric renal neoplasm, metanephric stromal tumor (MST).
Mean patient age was 2 years, and the most common presentation was that of an abdominal mass. Gross examination typically revealed a fibrous lesion centered in the renal medulla containing smooth-walled cysts (mean tumor size, 5.5 cm). MST is histologically identical to the stromal component of metanephric adenofibroma (MAF, previously termed nephrogenic adenofibroma) and is an unencapsulated spindle cell lesion that entraps native kidney.
Characteristic histologic features of MST include alternating cellularity that imparts a nodular low-power appearance, onion-skin cuffing around entrapped renal tubules, heterologous differentiation (glia or cartilage), and vascular alterations (angiodysplasia of entrapped arterioles, juxtaglomerular cell hyperplasia in entrapped glomeruli). Three tumors in which the vascular alterations were particularly florid were associated with extrarenal vasculopathy and attendant morbidity. A majority of cases stained for CD34, although the degree of staining was variable. Most patients were treated with surgical excision alone, and none experienced recurrence or metastasis.
Recognition of this entity can spare a child potentially toxic adjuvant chemotherapy that might be used for lesions in its differential diagnosis, specifically clear cell sarcoma of the kidney.
PROGNOSIS AND TREATMENT CHARACTERIZATION Prognostic Factors
Am J Surg Pathol 2000;24:4
Only histologic variable that independently correlated with survival was the presence of necrosis, typically a feature of aggressive high-grade sarcomas
Am J Surg Pathol 2000;24:4
High survival rate (98%) for patients with revised stage 1 disease
Updated NWTS 5 criteria, invasion of renal sinus vasculature, not gross protrusion beyond the hilar plane, is a basis of upstaging from stage 1 to stage 2
The long-held concept that stage 1 CCSKs disseminate early seems at variance with their slow growth rate, as reflected by the relatively low MIB-1 staining indices we obtained, the documented long intervals to recurrence, and the low percentage of patients who initially presented with stage 4 disease
Four revised stage 1 patients in this study who did not receive the benefit of doxorubicin therapy all survived, suggesting that these tumors were not disseminated and may have been cured by surgical excision
Am J Surg Pathol 2000;24:4
Bone is a favored site
Approximately 20% of documented CCSK metastases occurred 3 years or more after diagnosis and some as long as 10 years later
High (29%) frequency of lymph node metastases identified at presentation
Treatment Treatment of children with clear-cell sarcoma of the kidney: a report from the National Wilms' Tumor Study Group
J Clin Oncol 1994;12:2132–7.
Addition of doxorubicin (Adriamycin) to vincristine and dactinomycin improved the 6-year relapse-free survival for patients with CCSK
All patients with CCSK on NWTS trial 5 are now treated with doxorubicin regardless of stage
Hum Pathol 1985;16:1219–30.
Pediatr Pathol Lab Med 1989;9:211–8.
Macpherson and Pincus. Clinical Diagnosis and Management by Laboratory Methods. Twentyfirst Edition. WB Saunders. 2006.
Rosai J. Ackerman's Surgical Pathology. Ninth Edition. Mosby 2004.
Sternberg S. Diagnostic Surgical Pathology. Fourth Edition. Lipincott Williams and Wilkins 2004.
Robbins Pathologic Basis of Disease. Seventh Edition. WB Saunders 2005.
DeMay RM. The Art and Science of Cytopathology. Volume 1 and 2. ASCP Press. 1996.
Weedon D. Weedon's Skin Pathology Second Edition. Churchill Livingstone. 2002
Fitzpatrick's Dermatology in General Medicine. 6th Edition. McGraw-Hill. 2003.
Weiss SW and Goldblum JR. Enzinger and Weiss's Soft Tissue Tumors. Fourth Edition. Mosby 2001.
Commonly Used Terms
Basic Principles of Disease
Learn the basic disease classifications of cancers, infections, and inflammation
Commonly Used Terms
This is a glossary of terms often found in a pathology report.
Learn how a pathologist makes a diagnosis using a microscope
Surgical Pathology Report
Examine an actual biopsy report to understand what each section means
Understand the tools the pathologist utilizes to aid in the diagnosis
How Accurate is My Report?
Pathologists actively oversee every area of the laboratory to ensure your report is accurate
Recent teaching cases and lectures presented in conferences
Pathologists Who Make A Difference
Search for a Physician Specialist
Last Updated October 5, 2007
mail to The Doctor's Doctor with
questions or comments about this web site.
Read the Medical Disclaimer.
Copyright © The Doctor's Doctor